Skip to content

FUSE MEDICAL, INC.: 10-Q filed 2022-08-11

What FUSE MEDICAL, INC. reported in its quarterly report filed 2022-08-11 (fiscal Q2 2022): 44 published measures, 121 facts as tagged in accession 0001564590-22-029139.

This filing

Form
10-Q (quarterly report)
Filed
2022-08-11
Fiscal period
fiscal Q2 2022
Accession
0001564590-22-029139 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All FUSE MEDICAL, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-06-3019,052,829USD
At 2021-12-3118,304,492USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-06-3022,919,302USD
At 2021-12-3121,736,311USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-06-30-3,866,473USD
At 2022-03-31-3,777,256USD
At 2021-12-31-3,431,819USD
At 2021-06-30-2,465,621USD
At 2021-03-31-2,450,216USD
At 2020-12-31-2,112,841USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-93,319USD91
2022-01-01 to 2022-06-30-451,600USD181
2022-01-01 to 2022-03-31-358,281USD90
2021-04-01 to 2021-06-30-85,480USD91
2021-01-01 to 2021-06-30-538,803USD181
2021-01-01 to 2021-03-31-453,323USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-06-30670,878USD181
2021-01-01 to 2021-06-30169,418USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2022-01-01 to 2022-06-30422,973USD181

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2022-04-01 to 2022-06-304,668,290USD91
2022-01-01 to 2022-06-309,222,628USD181
2021-04-01 to 2021-06-305,665,015USD91
2021-01-01 to 2021-06-3010,105,774USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-197,099USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-422,973USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-06-30-6,067,799USD
At 2021-12-31-5,616,199USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2022-04-01 to 2022-06-3070,321,566shares91
2022-01-01 to 2022-06-3070,321,566shares181
2021-04-01 to 2021-06-3070,221,566shares91
2021-01-01 to 2021-06-3070,221,566shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-04-01 to 2022-06-300USD/shares91
2022-01-01 to 2022-06-30-0.01USD/shares181
2021-04-01 to 2021-06-300USD/shares91
2021-01-01 to 2021-06-30-0.01USD/shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2022-04-01 to 2022-06-305,171USD91
2022-01-01 to 2022-06-3010,027USD181
2021-04-01 to 2021-06-304,826USD91
2021-01-01 to 2021-06-309,186USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2022-06-30351,611USD
At 2021-12-317,251USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-01-01 to 2022-06-3016,946USD181
2021-01-01 to 2021-06-30186,023USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-51,621USD91
2022-01-01 to 2022-06-30-372,088USD181
2021-04-01 to 2021-06-30-426,006USD91
2021-01-01 to 2021-06-30-855,969USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-06-3013,021,353USD
At 2021-12-3112,824,577USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2022-04-01 to 2022-06-3036,527USD91
2022-01-01 to 2022-06-3069,485USD181
2021-04-01 to 2021-06-3016,048USD91
2021-01-01 to 2021-06-3035,048USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-06-3011,325,470USD
At 2021-12-3110,142,479USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2022-06-304,781,712USD
At 2021-12-314,461,641USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2022-06-301,972,886USD
At 2021-12-311,972,886USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2022-06-302,964,744USD
At 2021-12-313,528,992USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2022-04-01 to 2022-06-302,996,269USD91
2022-01-01 to 2022-06-306,245,883USD181
2021-04-01 to 2021-06-303,871,413USD91
2021-01-01 to 2021-06-306,888,270USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2022-06-309,357,282USD
At 2021-12-318,736,474USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2022-04-01 to 2022-06-302,944,648USD91
2022-01-01 to 2022-06-305,873,795USD181
2021-04-01 to 2021-06-303,445,407USD91
2021-01-01 to 2021-06-306,032,301USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2022-04-01 to 2022-06-301,723,642USD91
2022-01-01 to 2022-06-303,348,833USD181
2021-04-01 to 2021-06-302,219,608USD91
2021-01-01 to 2021-06-304,073,473USD181

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2022-04-01 to 2022-06-301,422,768USD91
2022-01-01 to 2022-06-303,132,309USD181
2021-04-01 to 2021-06-302,021,576USD91
2021-01-01 to 2021-06-303,456,887USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-06-3072,895,793shares
At 2021-12-3172,895,793shares

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2022-06-30443,222USD
At 2021-12-3120,249USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2022-06-3091,611USD
At 2021-12-3112,998USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2022-06-301,256,410USD
At 2021-12-311,317,341USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2022-06-303,953,587USD
At 2021-12-312,898,068USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2022-06-3095,331USD
At 2021-12-315,921USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-88,148USD91
2022-01-01 to 2022-06-30-441,573USD181
2021-04-01 to 2021-06-30-80,654USD91
2021-01-01 to 2021-06-30-529,617USD181

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-451,600USD181
2021-01-01 to 2021-06-30-538,803USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2022-04-01 to 2022-06-3056,209USD91
2022-01-01 to 2022-06-3078,613USD181
2021-04-01 to 2021-06-302,832USD91
2021-01-01 to 2021-06-306,992USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2022-01-01 to 2022-06-30144,044USD181
2021-01-01 to 2021-06-3032,258USD181

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2022-04-01 to 2022-06-3032,715USD91
2022-01-01 to 2022-06-3065,431USD181
2021-04-01 to 2021-06-3012,633USD91
2021-01-01 to 2021-06-3025,266USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-36,527USD91
2022-01-01 to 2022-06-30-69,485USD181
2021-04-01 to 2021-06-30345,352USD91
2021-01-01 to 2021-06-30326,352USD181

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2022-01-01 to 2022-06-3010,027USD181
2021-01-01 to 2021-06-309,186USD181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2022-01-01 to 2022-06-3050,796USD181
2021-01-01 to 2021-06-3021,235USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-666,843USD181
2021-01-01 to 2021-06-30-1,222,444USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-06-30526,213USD181
2021-01-01 to 2021-06-30897,793USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-06-30320,071USD181
2021-01-01 to 2021-06-301,068,299USD181

Inspect the source

Entity
FUSE MEDICAL, INC. / CIK 0000319016
Captured
2026-09-19T11:14:02.031Z
SEC response SHA-256
13d41024642d3becfdbc15fe6e31fdae11d4fa7a32679fcba6c1a612c57d756a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000319016.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))